/Companies

Vaccitech

7 known investors

Find your way into Vaccitech

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that direct T cells to address autoimmune and inflammatory diseases. Its work targets immunology and inflammatory (I&I) indications for patients.

Investors · 7

Also in the syndicate · 4

M&G Investment ManagementleadMonaco Constitutional Reserve FundOxford Sciences InnovationTencent

Funding

SEC filings, press & company announcements

$168M disclosed across 1 round · 2021

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Vaccitech do?
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that direct T cells to address autoimmune and inflammatory diseases. Its work targets immunology and inflammatory (I&I) indications for patients.
Who are Vaccitech's investors?
Vaccitech's investors include Future Planet Capital, GV (Google Ventures), Gilead Sciences.
How much funding has Vaccitech raised?
Vaccitech has disclosed $168M raised across 1 round.